Skip to main content

Advertising Disclaimer »

Main menu

  • Journals
    • Pediatrics
    • Hospital Pediatrics
    • Pediatrics in Review
    • NeoReviews
    • AAP Grand Rounds
    • AAP News
  • Authors/Reviewers
    • Submit Manuscript
    • Author Guidelines
    • Reviewer Guidelines
    • Open Access
    • Editorial Policies
  • Content
    • Current Issue
    • Online First
    • Archive
    • Blogs
    • Topic/Program Collections
    • AAP Meeting Abstracts
  • Pediatric Collections
    • COVID-19
    • Racism and Its Effects on Pediatric Health
    • More Collections...
  • AAP Policy
  • Supplements
  • Multimedia
    • Video Abstracts
    • Pediatrics On Call Podcast
  • Subscribe
  • Alerts
  • Careers
  • Other Publications
    • American Academy of Pediatrics

User menu

  • Log in
  • My Cart

Search

  • Advanced search
American Academy of Pediatrics

AAP Gateway

Advanced Search

AAP Logo

  • Log in
  • My Cart
  • Journals
    • Pediatrics
    • Hospital Pediatrics
    • Pediatrics in Review
    • NeoReviews
    • AAP Grand Rounds
    • AAP News
  • Authors/Reviewers
    • Submit Manuscript
    • Author Guidelines
    • Reviewer Guidelines
    • Open Access
    • Editorial Policies
  • Content
    • Current Issue
    • Online First
    • Archive
    • Blogs
    • Topic/Program Collections
    • AAP Meeting Abstracts
  • Pediatric Collections
    • COVID-19
    • Racism and Its Effects on Pediatric Health
    • More Collections...
  • AAP Policy
  • Supplements
  • Multimedia
    • Video Abstracts
    • Pediatrics On Call Podcast
  • Subscribe
  • Alerts
  • Careers

Discover Pediatric Collections on COVID-19 and Racism and Its Effects on Pediatric Health

American Academy of Pediatrics

This policy is a revision of the policy in

  • 114(1):297
AMERICAN ACADEMY OF PEDIATRICS

Practice Parameter: Management of Hyperbilirubinemia in the Healthy Term Newborn

; PROVISIONAL COMMITTEE ON QUALITY IMPROVEMENT and ; SUBCOMMITTEE ON HYPERBILIRUBINEMIA
Pediatrics October 1994, 94 (4) 558-565;
  • Article
  • Info & Metrics
  • Comments
Loading
Download PDF

Abstract

Each year approximately 60% of the 4 million newborns in the United States become clinically jaundiced. Many receive various forms of evaluation and treatment. Few issues in neonatal medicine have generated such long-standing controversy as the possible adverse consequences of neonatal jaundice and when to begin treatment. Questions regarding potentially detrimental neurologic effects from elevated serum bilirubin levels prompt continuing concern and debate, particularly with regard to the management of the otherwise healthy term newborn without risk factors for hemolysis. Although most data are based on infants with birth weights ≥2500 g, "term" is hereafter defined as 37 completed weeks of gestation.

Under certain circumstances, bilirubin may be toxic to the central nervous system and may cause neurologic impairment even in healthy term newborns. Most studies, however, have failed to substantiate significant associations between a specific level of total serum bilirubin (TSB) during nonhemolytic hyperbilirubinemia in term newborns and subsequent IQ or serious neurologic abnormality (including hearing impairment). Other studies have detected subtle differences in outcomes associated with TSB levels, particularly when used in conjunction with albumin binding tests and/or duration of exposure. In almost all published studies, the TSB concentration has been used as a predictor variable for outcome determinations.

Factors influencing bilirubin toxicity to the brain cells of newborn infants are complex and incompletely understood; they include those that affect the serum albumin concentration and those that affect the binding of bilirubin to albumin, the penetration of bilirubin into the brain, and the vulnerability of brain cells to the toxic effects of bilirubin.

  • Copyright © 1994 by the American Academy of Pediatrics
PreviousNext
Back to top

Advertising Disclaimer »

In this issue

Pediatrics
Vol. 94, Issue 4
1 Oct 1994
  • Table of Contents
  • Index by author
PreviousNext
Email Article

Thank you for your interest in spreading the word on American Academy of Pediatrics.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Practice Parameter: Management of Hyperbilirubinemia in the Healthy Term Newborn
(Your Name) has sent you a message from American Academy of Pediatrics
(Your Name) thought you would like to see the American Academy of Pediatrics web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Request Permissions
Article Alerts
Log in
You will be redirected to aap.org to login or to create your account.
Or Sign In to Email Alerts with your Email Address
Citation Tools
Practice Parameter: Management of Hyperbilirubinemia in the Healthy Term Newborn
Pediatrics Oct 1994, 94 (4) 558-565;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Practice Parameter: Management of Hyperbilirubinemia in the Healthy Term Newborn
Pediatrics Oct 1994, 94 (4) 558-565;
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
Download PDF
Insight Alerts
  • Table of Contents

Jump to section

  • Article
  • Info & Metrics
  • Comments

Related Articles

  • Management of Hyperbilirubinemia in the Newborn Infant 35 or More Weeks of Gestation
  • PubMed
  • Google Scholar

Cited By...

  • Determinants of neonatal jaundice among neonates admitted to five referral hospitals in Amhara region, Northern Ethiopia: an unmatched case-control study
  • Exposure to Phototherapy and Childhood Seizure Risk
  • Phototherapy and Seizures: Should We Change Practice?
  • Safety and Immunogenicity of the Recombinant Mycobacterium bovis BCG Vaccine VPM1002 in HIV-Unexposed Newborn Infants in South Africa
  • Transcutaneous Bilirubin After Phototherapy in Term and Preterm Infants
  • Visuocortical Function in Infants With a History of Neonatal Jaundice
  • Legal Briefs: Kernicterus--Still Preventable
  • Evidence Suggests There Was Not a "Resurgence" of Kernicterus in the 1990s
  • Effect of Neonatal Jaundice and Phototherapy on the Frequency of First-Year Outpatient Visits
  • Range of UK practice regarding thresholds for phototherapy and exchange transfusion in neonatal hyperbilirubinaemia
  • Neonatal jaundice: in the eye of the beholder?
  • Interaction of Hemolysis and Hyperbilirubinemia on Neurodevelopmental Outcomes in the Collaborative Perinatal Project
  • Trends in Hospitalizations for Neonatal Jaundice and Kernicterus in the United States, 1988-2005
  • Outcomes in a Population of Healthy Term and Near-Term Infants With Serum Bilirubin Levels of >=325 {micro}mol/L (>=19 mg/dL) Who Were Born in Nova Scotia, Canada, Between 1994 and 2000
  • Readmission for Neonatal Jaundice in California, 1991-2000: Trends and Implications
  • Ontogeny of Bilirubin-Binding Capacity and the Effect of Clinical Status in Premature Infants Born at Less Than 1300 Grams
  • Preventing kernicterus: a wake-up call
  • A Decline in the Frequency of Neonatal Exchange Transfusions and Its Effect on Exchange-Related Morbidity and Mortality
  • Preventable Newborn Readmissions Since Passage of the Newborns' and Mothers' Health Protection Act
  • Effect of Predischarge Bilirubin Screening on Subsequent Hyperbilirubinemia: In Reply
  • Surveillance of severe neonatal hyperbilirubinemia: a view from south of the border.
  • Incidence and causes of severe neonatal hyperbilirubinemia in Canada.
  • Impact of Postpartum Hospital-Stay Legislation on Newborn Length of Stay, Readmission, and Mortality in California
  • Rebound bilirubin: on what should the decision to recommence phototherapy be based? * Authors' reply
  • The Effect of Instituting a Prehospital-Discharge Newborn Bilirubin Screening Program in an 18-Hospital Health System
  • Toward Understanding Kernicterus: A Challenge to Improve the Management of Jaundiced Newborns
  • Post-phototherapy neonatal bilirubin rebound: a potential cause of significant hyperbilirubinaemia
  • American Academy of Pediatrics guidelines for detecting neonatal hyperbilirubinaemia and preventing kernicterus
  • American Academy of Pediatrics guidelines for detecting neonatal hyperbilirubinaemia and preventing kernicterus
  • Breastfeeding-Associated Hypernatremia: Are We Missing the Diagnosis?
  • Vigintiphobia Revisited
  • Hyperbilirubinemia Guidelines in Newborn Infants
  • Cost-Effectiveness of Postnatal Home Nursing Visits for Prevention of Hospital Care for Jaundice and Dehydration
  • Hyperbilirubinemia Guidelines and Unintended Harms: In Reply
  • Conflict of Interest and Purpose in Bilirubin Screening: In Reply
  • Hyperbilirubinemia Guidelines and Unintended Harms
  • Management of Hyperbilirubinemia in Newborns: Measuring Performance Using a Benchmarking Model
  • Hyperbilirubinemia Benchmarking
  • Hyperbilirubinemia Among African American, Glucose-6-Phosphate Dehydrogenase-Deficient Neonates
  • Closing the Gap Between Guidelines and Practice: Ensuring Safe and Healthy Beginnings
  • Management of Hyperbilirubinemia in the Newborn Infant 35 or More Weeks of Gestation
  • Hyperbilirubinemia Benchmarking
  • Research on Prevention of Bilirubin-Induced Brain Injury and Kernicterus: National Institute of Child Health and Human Development Conference Executive Summary
  • Intervention Recommendations for Neonatal Hyperbilirubinemia
  • Hospital Stay for Healthy Term Newborns
  • Incidence, Course, and Prediction of Hyperbilirubinemia in Near-Term and Term Newborns
  • Urgent Clinical Need for Accurate and Precise Bilirubin Measurements in the United States to Prevent Kernicterus
  • Infants With Bilirubin Levels of 30 mg/dL or More
  • Performance of Bilirubin Determinations in US Laboratories--Revisited
  • The power of stories over statistics
  • Corrected End-Tidal Carbon Monoxide Closely Correlates With the Corrected Reticulocyte Count in Coombs' Test-Positive Term Neonates
  • Management of Hyperbilirubinemia in Newborns: Measuring Performance by Using a Benchmarking Model
  • Applying the "10 Simple Rules" of the Institute of Medicine to Management of Hyperbilirubinemia in Newborns
  • How to Make Kernicterus a "Never Event"
  • Umbilical Cord Care in Premature Infants: The Effect of Two Different Cord-Care Regimens (Salicylic Sugar Powder vs Chlorhexidine) on Cord Separation Time and Other Outcomes
  • Transcutaneous bilirubin measurement in newborn infants: evaluation of a new spectrophotometric method
  • Infants With Bilirubin Levels of 30 mg/dL or More in a Large Managed Care Organization
  • Phototherapy Use in Jaundiced Newborns in a Large Managed Care Organization: Do Clinicians Adhere to the Guideline?
  • Unbound Bilirubin in a Term Newborn With Kernicterus
  • Bilirubin Genetics for the Nongeneticist: Hereditary Defects of Neonatal Bilirubin Conjugation
  • Induction of bilirubin clearance by the constitutive androstane receptor (CAR)
  • Measuring Bilirubin Through the Skin?
  • Kernicterus: Past, Present, and Future
  • Moderate Hyperbilirubinemia Induces a Transient Alteration of Neonatal Behavior
  • A comparison of transcutaneous bilirubinometers: SpectRx BiliCheck versus Minolta AirShields
  • Isoimmunization Is Unlikely to Be the Cause of Hemolysis in ABO-Incompatible but Direct Antiglobulin Test-Negative Neonates
  • Jaundice as an Early Diagnostic Sign of Urinary Tract Infection in Infancy
  • An Early (Sixth-Hour) Serum Bilirubin Measurement Is Useful in Predicting the Development of Significant Hyperbilirubinemia and Severe ABO Hemolytic Disease in a Selective High-Risk Population of Newborns With ABO Incompatibility
  • Total Bilirubin Measurement by Photometry on a Blood Gas Analyzer: Potential for Use in Neonatal Testing at the Point of Care,
  • Neonatal Jaundice and Kernicterus
  • Kernicterus in Full-Term Infants Is Still a Problem in the US
  • Transcutaneous Bilirubin Measurement: A Multicenter Evaluation of a New Device
  • Increased vigilance needed to prevent kernicterus in newborns
  • Developmental Follow-Up of Breastfed Term and Near-Term Infants With Marked Hyperbilirubinemia
  • Noninvasive Measurement of Total Serum Bilirubin in a Multiracial Predischarge Newborn Population to Assess the Risk of Severe Hyperbilirubinemia
  • Breastfeeding, Diet, and Neonatal Hyperbilirubinemia
  • Less Aggressive Treatment of Neonatal Jaundice and Reports of Kernicterus: Lessons About Practice Guidelines
  • Frequency of Neonatal Bilirubin Testing and Hyperbilirubinemia in a Large Health Maintenance Organization
  • Predicting Hyperbilirubinemia in Newborns: The Importance of Timing
  • Evidence-Based Guidelines and Critical Pathways for Quality Improvement
  • Predictive Ability of a Predischarge Hour-specific Serum Bilirubin for Subsequent Significant Hyperbilirubinemia in Healthy Term and Near-term Newborns
  • Control of Severe Hyperbilirubinemia in Full-term Newborns With the Inhibitor of Bilirubin Production Sn-Mesoporphyrin
  • Pediatricians' Awareness of and Attitudes About Four Clinical Practice Guidelines
  • Control of Hyperbilirubinemia in Glucose-6-Phosphate Dehydrogenase-deficient Newborns Using an Inhibitor of Bilirubin Production, Sn-Mesoporphyrin
  • Personal Reflections on the AAP Practice Parameter on Management of Hyperbilirubinemia in the Healthy Term Newborn
  • Kernicteric Findings at Autopsy in Two Sick Near Term Infants
  • Practice Patterns in Neonatal Hyperbilirubinemia
  • Recognition of the Presence and Severity of Newborn Jaundice by Parents, Nurses, Physicians, and Icterometer
  • Carbon Monoxide and Bilirubin Production in Neonates
  • Early Discharge From the Newborn Nursery---Effect on Scheduling of Follow-up Visits by Pediatricians
  • The Status of Pediatric Practice Guidelines
  • Adverse Events Associated With Exchange Transfusion in Healthy and Ill Newborns
  • Breastfeeding Update 2: Clinical Lactation Management
  • Clinical Practice Guidelines in Pediatric and Newborn Medicine: Implications for Their Use in Practice
  • Google Scholar

More in this TOC Section

  • Exposure to Nontraditional Pets at Home and to Animals in Public Settings: Risks to Children
  • Medical Emergencies Occurring at School
  • Disaster Planning for Schools
Show more AMERICAN ACADEMY OF PEDIATRICS

Similar Articles

  • Journal Info
  • Editorial Board
  • Editorial Policies
  • Overview
  • Licensing Information
  • Authors/Reviewers
  • Author Guidelines
  • Submit My Manuscript
  • Open Access
  • Reviewer Guidelines
  • Librarians
  • Institutional Subscriptions
  • Usage Stats
  • Support
  • Contact Us
  • Subscribe
  • Resources
  • Media Kit
  • About
  • International Access
  • Terms of Use
  • Privacy Statement
  • FAQ
  • AAP.org
  • shopAAP
  • Follow American Academy of Pediatrics on Instagram
  • Visit American Academy of Pediatrics on Facebook
  • Follow American Academy of Pediatrics on Twitter
  • Follow American Academy of Pediatrics on Youtube
  • RSS
American Academy of Pediatrics

© 2021 American Academy of Pediatrics